94766 ⎘
Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms; Nitrogen atoms; Acylated amino or imino radicals by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof, e.g. carbonylguanidines
SMALL MOLECULE SIRTUIN INHIBITORS AND USES THEREOF
#2ARYL HYDROCARBON RECEPTOR (AHR) AGONISTS AND USES THEREOF
#3MODULATORS OF THE PROSTACYCLIN (PGI2) RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO
#4CDK19-Selective Inhibitors, and Methods of Use Thereof
#5MODULATORS OF THE PROSTACYCLIN (PGI2) RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO
#6CARBOXYLIC ACID-CONTAINING COMPOUNDS AS MODULATORS OF BIS-PHOSPHOGLYCERATE MUTASE FOR THE TREATMENT OF SICKLE CELL DISEASE
#7Aryl hydrocarbon receptor (AHR) agonists and uses thereof
#8MODULATORS OF THE PROSTACYCLIN (PGI2) RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO
#9Pesticidal compositions and methods
#10Aryl hydrocarbon receptor (AHR) agonists and uses thereof
#11MODULATORS OF THE PROSTACYCLIN (PGI2) RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO
#12Biguanide derivatives and their rearrangement products for use in the treatment of cancer
#13Hydrogen sulfide donor in organic salt form and preparation method therefor
#14CHEMICAL SYNTHESIS
#15Haptens, hapten conjugates, compositions thereof and method for their preparation and use
#16Modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related thereto
#17GUANIDINE COMPOUNDS AND USE THEREOF AS BINDING PARTNERS FOR 5-HT5 RECEPTORS
#18Compound, organic cation transporter 3 detection agent, and organic cation transporter 3 activity inhibitor
#19TrkA kinase inhibitors, compositions and methods thereof
#20Aromatic 5-membered heterocyclic derivative having TRPV4-Inhibiting activity
#21Fungicidal 4-substituted-3-{phenyl[(heterocyclylmethoxy)imino]methyl}-1,2,4-oxadizol-5(4H)-one derivatives
#22Methods for modulating bacterial virulence and related compounds
#23Phenyl-guanidine derivatives
#24Amidine compound or salt thereof
#25Alkylamidothiazoles, cosmetic or dermatological preparations containing said alkylamidothiazoles, and use thereof to combat or prevent undesired pigmentation of the skin
#26Guanidine compounds, and use thereof as binding partners for 5-HT5 receptors
#27Process for the Production of 2-Amino-5-Fluorothiazole
#28MODULATORS OF THE PROSTACYCLIN (PGI2) RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO
#29Fungicide hydroximoyl-heterocycles derivatives
#30Cosmetic or dermatological preparations with a content of one or more thiazole derivates
#31Heterocyclic CETP inhibitors
#32UREA DERIVATIVES, METHODS FOR THEIR MANUFACTURE, AND USES THEREFOR
#33Thiazole derivatives for the treatment of diseases such as cancer
#34Urea glucokinase activators
#35LIBRARIES OF N-SUBSTITUTED-N-PHENYLETHYLSULFONAMIDES FOR DRUG DISCOVERY
#36LIBRARIES OF N-SUBSTITUTED-N-PHENYLETHYLSULFONAMIDES FOR THE IDENTIFICATION OF BIOLOGICAL AND PHARMACOLOGICAL ACTIVITY
#37UREA DERIVATIVES HAVING PI3K-INHIBITING ACTIVITY
#38TASPASE1 inhibitors and their uses
#39Antibacterial amide and sulfonamide substituted heterocyclic urea compounds
#40MODULATORS OF CYTOKINE MEDIATED SIGNALLING PATHWAYS AND INTEGRIN ALPHAVBETA3 RECEPTOR ANTAGONISTS FOR COMBINATION THERAPY
#41ARYL CARBONYL DERIVATIVES AS THERAPEUTIC AGENTS
#42Guanidine compounds, and use thereof as binding partners for 5-HT5 receptors
#435-PHENYL-4-METHYL-THIAZOL-2-YL-AMINE DERIVATIVES AS INHIBITORS OF PHOSPHATIDYLINOSITOL 3 KINASE ENZYMES (PI3) FOR THE TREATMENT OF INFLAMMATORY DISEASES
#445-PHENYL-4-METHYL-THIAZOL-2-YL-AMINE DERIVATIVES AS INHIBITORS OF PHOSPHATIDYLINOSITOL 3 KINASE ENZYMES (PI3) FOR THE TREATMENT OF INFLAMMATORY DISEASES
#45Nitrogen-containing aromatic derivatives
#46Methods of chemotype evolution
#47Compounds as cannabinoid receptor ligands and uses thereof
#48Urea glucokinase activators
#49Heteroaryl-ureas and their use as glucokinase activators
#50Modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related thereto
#51Thiazol-Guanidine Derivatives Useful As A (Beta)-Related Pathologies
#52Haptens, hapten conjugates, compositions thereof and method for their preparation and use
#53Antibacterial sulfone and sulfoxide substituted heterocyclic urea compounds
#54Heterocyclic CETP inhibitors
#55Compounds that modulate PPARγ-type receptors and cosmetic/pharmaceutical compositions comprising said compounds
#56Benzamidine derivatives, process for the preparation thereof and pharmaceutical composition comprising the same
#57Urea derivatives methods for their manufacture and uses thereof
#58Heteroaryl-ureas and their use as glucokinase activators
#59Nitrogen-containing aromatic derivatives
#60Haptens, hapten conjugates, compositions thereof and method for their preparation and use
#61Novel Heterocyclic Compounds
#62Sphingosine Kinase Inhibitors and Methods of Their Use
#63Inhibitors of carnitine palmitoyltransferase and treating cancer
#64COMPOUNDS USEFUL FOR INHIBITING CHK1
#65Methods of modulating PPAR gamma-type receptors
#66Compounds as cannabinoid receptor ligands and uses thereof
#675-phenylthiazole derivatives and use as PI3 kinase inhibitors
#68Urea glucokinase activators
#694-(3,3-DIHALO-ALLYLOXY)PHENOL DERIVATIVES HAVING PESTICIDAL PROPERTIES
#70Malonyl-CoA decarboxylase inhibitors useful as metabolic modulators
#71THIAZOLE DERIVATIVES AS INHIBITORS OF P13 KINASE
#72Urea glucokinase activators
#73Inhibitors of the endothelin signalling pathway and alphavbeta3 integrin receptor antagonists for combination therapy
#745-phenyl-thiazol-2-yl-urea derivatives and use as PI3 kinase inhibitors
#75Heteroaryl-ureas and their use as glucokinase activators
#76Methods, compounds and compositions with genotype selective anticancer activity
#77Dicycloalkyl urea glucokinase activators
#78Ureido-thiazole glucokinase activators
#79DEUTERIUM-ENRICHED FAMOTIDINE
#80Organic compounds
#81Modulators of Chemokine Receptor Activity
#825-phenyl-4-methyl-thiazol-2-yl-amine derivatives as inhibitors of phosphatidylin ositol 3 kinase enzymes (PI13) for treatment of inflammatory diseases
#83Haptens, hapten conjugates, compositions thereof and method for their preparation and use
#845-Substituted Thiazol-2-Yl Amino Compounds and Compositions as Protein Kinase Inhibitors
#85Benzamidine derivatives having anti-inflammatory and immunosuppressive activity
#86Antibacteriall heterocyclic ureas
#87Thiazole derivatives and use thereof
#88Alkyl urea substituted pyridines
#89Derivatives of urea and related diamines, methods for their manufacture, and uses therefor
#90Aryl carbonyl derivatives as therapeutic agents
#91Aryl carbonyl derivatives as therapeutic agents
#92Adamantyl acetamides as 11-β hydroxysteroid dehydrogenase inhibitors
#93Compounds as cannabinoid receptor ligands and uses thereof
#94Compounds as cannabinoid receptor ligands and uses thereof
#95Guanidine compounds, and use thereof as binding partners for 5-HT5 receptors
#96FBPase inhibitors for diabetes
#97Substituted Aminothiazole Derivatives With Anti-HCV Activity
#98Calcium channel antagonists
#99Heterocyclic CETP inhibitors
#100Novel benzamidine derivatives having anti-inflammatory and immunosuppressive activity
#101Biaryl substituted thiazoles, oxazoles and imidazoles as sodium channel blockers
#102VLA-4 inhibitor compounds
#103Heteroaryl-ureas and their use as glucokinase activators
#104SPHINGOSINE KINASE INHIBITORS AND METHODS OF THEIR USE
#105Biarylurea derivatives
#106Nitrosated and nitrosylated Hreceptor antagonist compounds, compositions and methods of use
#107Thiazole derivatives
#108Nitrogen-containing aromatic derivatives
#109New 2-substituted - 1,3-thiazole compounds
#110Aryl carbonyl derivatives as therapeutic agents
#111Urea inhibitors of MAP kinases
#112Cell adhesion inhibitors
#113Diarylurea derivatives and their use as chloride channel blockers
#114Nitrogen-containing aromatic derivatives
#115Modulators of cytokine mediated signaling pathways and integrin alphabeta3 receptor antagonists for combination therapy
#116Compounds that modulate PPARγ type receptors and cosmetic/pharmaceutical compositions comprised thereof
#117Thiazole derivatives
#118Inhibitors of HIV-1 capsid formation: substituted aryl aminomethyl thiazole ureas and analogues thereof
#119Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors
#120Multicyclic compounds which inhibit leukocyte adhesion mediated by VLA-4
#121Thiazole-based nitric oxide donors capable of releasing two or more nitric oxide molecules and uses thereof
#1224-(3,3-dihalo-allyloxy) phenol derivatives having pesticidal properties
#123Positive allosteric modulators of the nicotinic acetylcholine receptor
#124Nitrosated and nitrosylated Hreceptor antagonist compounds, compositions and methods of use
#125Urea or thiourea substituted 1,4-pyrazine compounds useful as anti-cancer agents and for inhibiting Chk1
#126Pyrazinone derivatives
#127N-ureidoalkyl-amino compounds as modulators of chemokine receptor activity
#128HIV protease inhibiting compounds
#1292-substituted-1,3-thiazole compounds
#1305-phenylthiazole derivatives and use as Pi3 kinase inhibitors
#131Chemical complex comprising a pyridine carboxy derivative and an H2 histamine receptor antagonist
#132Heterocyclic amide compounds as apolipoprotein b inhibitors